InfuSystem Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by InfuSystem Holdings, Inc. on March 7, 2020, covering events reported as of that date. The filing primarily addresses the appointment of a new Chief Financial Officer and the conclusion of the interim CFO's tenure.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes
The primary material change is the appointment of Barry G. Steele as Executive Vice President and Chief Financial Officer, effective upon the filing of the Company's Form 10-K for the period ended December 31, 2019. Concurrently, Wesley Winnekins' responsibilities as Interim Chief Financial Officer and principal financial officer concluded.
Guidance, Outlook, and Compensation Details
The filing details the terms of Mr. Steele's Employment Agreement, effective March 11, 2020:
- Base Salary: $275,000 annually.
- Performance Bonus: Eligible for up to 40% of base salary ($110,000) based on objectives set by the Compensation Committee.
- Sign-on Bonus: $50,000.
- Equity Compensation: Contingent on Compensation Committee approval, Mr. Steele will receive stock options for 50,000 shares (vesting annually over three years) and 30,000 restricted stock units (vesting in full on the third anniversary).
- Severance: In the event of involuntary termination without cause, Mr. Steele is entitled to three months of base salary and three months of COBRA coverage, contingent upon signing a general release.
The agreement is "at-will," allowing termination by either party at any time. No specific financial guidance or outlook for the company's operations was provided in this filing.
Investor Verification Checklist
- Verify the exact effective date of the CFO transition relative to the Form 10-K filing for the year ended December 31, 2019.
- Confirm the Compensation Committee's approval status for the proposed stock options and restricted stock units.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "Termination for Cause" and performance metrics.
- Check subsequent filings for the actual vesting dates and grant prices of the equity awards.